Matthew Coll, Vice President of Market Insights at COEUS, has more than 15 years of experience leading healthcare policy research and nearly a decade of experience specializing in market access research. He has led and advised on a wide range of market research engagements focused on pricing, market access, and contracting strategy. Matthew has led engagements in both US and EU markets and across a wide range of therapeutic areas, including rare/orphan diseases, oncology, neurology, and high prevalence/competitive categories such as diabetes, asthma/COPD, and immunology.

Prior to joining COEUS, Matthew worked at Trinity Life Sciences and Health Strategies Group (now Eversana), where he designed and executed market research engagements to help biotech and pharma clients optimize their market access strategies.